Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond A review of animal and human studies

Abstract : The long-term impact of selective serotonin reuptake inhibitor (SSRI) antidepressant treatment during pregnancy and postpartum on offspring outcomes is still not clear. Specifically, perinatal SSRI exposure may have long-term consequences for body weight and related health outcomes in the newborn period and beyond. This review focuses on the impact of perinatal SSRI exposure on weight using human and animal findings. The impact of maternal mood is also explored. We propose potential mechanisms for weight changes, including how early alterations in serotonin signaling may have implications for weight via changes in metabolism and motor development. As the majority of serotonin is in the gastrointestinal (GI) system we also speculate that perinatal SSRI exposure might alter the brain-gut relationship, via the microbiome, leading to changes in feeding behavior and weight.
Document type :
Journal articles
Complete list of metadatas

Cited literature [150 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01740002
Contributor : Laurent Jonchère <>
Submitted on : Friday, July 6, 2018 - 9:15:17 AM
Last modification on : Wednesday, October 30, 2019 - 1:19:19 AM
Long-term archiving on : Tuesday, October 2, 2018 - 3:12:15 AM

File

Hutchison et al_Perinatal Sele...
Files produced by the author(s)

Identifiers

Citation

Sarah Hutchison, Louise Mâsse, Jodi Pawluski, Tim Oberlander. Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond A review of animal and human studies. Reproductive Toxicology, Elsevier, 2018, 77, pp.109-121. ⟨10.1016/j.reprotox.2018.02.004⟩. ⟨hal-01740002⟩

Share

Metrics

Record views

232

Files downloads

270